Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"TRPC6 pseudogene 9" (TRPC6P9) is a pseudogene annotated as related to the protein-coding TRPC6 gene. Unlike TRPC6—which encodes a non-selective cation channel involved in calcium signaling, cell proliferation, immune response, and several diseases—the pseudogene TRPC6P9 does not produce a functional protein and is not considered a receptor, transporter, enzyme, or therapeutic target. Pseudogenes such as TRPC6P9 generally arise from gene duplication or retrotransposition but lack the ability to encode a functional product and are thus not involved in physiological processes or disease mechanisms as protein-coding genes are[5][7]. There is no evidence in current biomedical literature that TRPC6P9 is a biologically relevant molecule, a disease marker, or a drug target. Key points: - This is not a real therapeutic target (it is a pseudogene; not a receptor or an ion channel). - There is potential for confusion with TRPC6 (the functional calcium channel), which is a true target protein involved in disease and drug interaction[1][2][7]. - If you require information on the actual functional TRPC6 protein, clarify your query accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRPC6 pseudogene 9 (TRPC6P9).